Responsiveness among patient-reported measures of quality of life, quality of sleep, and functional disability to pain and impact of buprenorphine transdermal system (BTDS) treatment in chronic low back pain patients
Abstract
Authors
A. Yarlas K. Miller W. Wen R. Shah S.Y. Lynch B. Dain S.R. Ripa